Bromide

Bromide

SCHEMBL368455

Br.Br.Br.C=CC[N+](CC=C)(CC=C)CC=C

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL368454 0.96
SCHEMBL197824 0.96 TSHR (0.33) TSHRALDH1A1
Hydrogen Sulfide SCHEMBL28090943 0.96 TSHR (0.33) TSHRALDH1A1
Bromide SCHEMBL28874797 0.93
Fluoride Ion SCHEMBL33106 0.92 TSHR (0.31) TSHRALDH1A1
Iodide SCHEMBL2796494 0.92 TSHR (0.31) TSHRALDH1A1
Hydrochloric Acid SCHEMBL20896 0.92 TSHR (0.31) TSHRALDH1A1
SCHEMBL5327324 0.92 TSHR (0.31) TSHRALDH1A1
Lithium Ion SCHEMBL2504315 0.92 TSHR (0.31) TSHRALDH1A1
Fluoride Ion SCHEMBL1260645 0.92 TSHR (0.31) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174687-A1 PROCESS FOR THE PREPARATION OF BROMINATED COPOLYMERS OF CONJUGATED DIENES AND STYRENIC MONOMERS LANXESS CORPORATION (US) 2023-06-08 US claimed
US-8779066-B2 Process for brominating butadiene polymers using ester solvent mixtures DOW GLOBAL TECHNOLOGIES LLC (US) 2014-07-15 US claimed
US-20140121330-A1 PROCESS FOR BROMINATING BUTADIENE POLYMERS USING ESTER SOLVENT MIXTURES THE DOW CHEMICAL COMPANY 2014-05-01 US claimed
EP-2379605-B1 PROCESS FOR BROMINATING BUTADIENE POLYMERS USING ESTER SOLVENT MIXTURES DOW GLOBAL TECHNOLOGIES LLC (US) 2014-03-12 EP claimed
US-8410226-B2 Two-step process for brominating butadiene copolymers DOW GLOBAL TECHNOLOGIES LLC (US) 2013-04-02 US claimed
EP-2274338-B1 TWO-STEP PROCESS FOR BROMINATING BUTADIENE COPOLYMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-12-12 EP claimed
US-8193287-B2 Process for brominating butadiene copolymers by the addition of water or certain solvents DOW GLOBAL TECHNOLOGIES LLC (US) 2012-06-05 US claimed
JP-2011528380-A 2011-11-17 JP claimed
EP-2379605-A1 PROCESS FOR BROMINATING BUTADIENE POLYMERS USING ESTER SOLVENT MIXTURES Dow Global Technologies LLC (US) 2011-10-26 EP claimed
JP-4726778-B2 2011-07-20 JP claimed
US-20100004402-A1 Process for brominating butadiene/vinyl aromatic copolymers THE DOW CHEMICAL COMPANY 2010-01-07 US claimed
WO-2009139942-A2 PROCESS FOR BROMINATING BUTADIENE COPOLYMERS BY THE ADDITION OF WATER OR CERTAIN SOLVENTS DOW GLOBAL TECHNOLOGIES INC. (US) 2009-11-19 WO claimed
WO-2009134628-A1 TWO-STEP PROCESS FOR BROMINATING BUTADIENE COPOLYMERS DOW GLOBAL TECHNOLOGIES INC. (US) 2009-11-05 WO claimed
US-7605267-B2 Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones NOVARTIS AG (CH) 2009-10-20 US claimed
EP-2054445-A2 PROCESS FOR BROMINATING BUTADIENE/VINYL AROMATIC COPOLYMERS Dow Global Technologies Inc. (US) 2009-05-06 EP claimed
WO-2008021417-A2 PROCESS FOR BROMINATING BUTADIENE/VINYL AROMATIC COPOLYMERS DOW GLOBAL TECHNOLOGIES, INC. (US) 2008-02-21 WO claimed
JP-2006522055-A 2006-09-28 JP claimed
US-20060189653-A1 Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones NOVARTIS AG (CH) 2006-08-24 US claimed
EP-1613599-A1 A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES Novartis AG (CH) 2006-01-11 EP claimed
WO-2004087668-A1 A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES NOVARTIS AG (CH) 2004-10-14 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189653-A1 Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones UGT8, KAT8, UGT1A8 TSHR 1260/4885ALDH1A1 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.